# Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial

> **NCT07467343** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 140 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Silodosin
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT07467343
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-22
- **Primary completion:** 2026-09-22
- **Final completion:** 2026-10-22
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07467343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07467343, "Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07467343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*